
9/17/2019

WHEN: 8 to 11:30 a.m., Friday, Sept. 20, 2019.
WHERE: G23 Public Health Auditorium, University of Pittsburgh Graduate School of Public Health, 130 Desoto St., Pittsburgh, Pa., 15213.
WHY: Since enrolling its first participant in 1984, the Pitt Men’s Study has signed up 1,713 participants, 827 of whom are currently active in the study. The data that these Pittsburgh participants provided have contributed to many milestones — including antiretroviral therapy to delay the onset of AIDS and pre-exposure prophylaxis medications to prevent people from contracting HIV — that changed HIV from an acute, deadly illness to a chronic, manageable condition. Ongoing research at Pitt is exploring an immunotherapy “cure” that may allow people with HIV to stop taking daily medications to keep the virus in check.
WHO:
- Arthur Levine, M.D., senior vice chancellor, Pitt Schools of the Health Sciences, and John and Gertrude Petersen Dean of Pitt’s School of Medicine.
- Charles Rinaldo, Ph.D., principal investigator of the Pitt Men’s Study, chair and professor of Pitt Public Health’s Department of Infectious Diseases and Microbiology.
- Frank Palella, M.D., Potocsnak Family Professor of Medicine at Northwestern University’s Feinberg School of Medicine.
- William Buchanan, M.Mus., clinic and volunteer coordinator for the Pitt Men’s Study.
- Phyllis Tien, M.D., professor of medicine, University of California, San Francisco, School of Medicine.
- Jeremy Martinson, D.Phil., co-principal investigator of the Pitt Men’s Study, assistant professor, Pitt Public Health’s Department of Infectious Diseases and Microbiology.
Note to Media: To cover this event, prearrangements must be made by contacting Allison Hydzik at 412-647-9975 or HydzikAM@upmc.edu.